Open access · CC-BY
via OpenAlex
Orexin and Alzheimer’s Disease
Current topics in behavioral neurosciences · 2016 · ▲ 73 citations
Abstract
Alzheimer's disease (AD) is the most frequent age-related dementia. It prevalently causes cognitive decline, although it is frequently associated with secondary behavioral disturbances. AD neurodegeneration characteristically produces a remarkable destruction of the sleep-wake cycle, with diurnal napping, nighttime arousals, sleep fragmentation, and REM sleep impairment. It was recently hypothesized that the orexinergic system was involved in AD pathology. Accordingly, recent papers showed the association between orexinergic neurotransmission dysfunction, sleep impairment, and cognitive decline in AD. Orexin is a hypothalamic neurotransmitter which physiologically produces wakefulness and reduces REM sleep and may alter the sleep-wake cycle in AD patients. Furthermore, the orexinergic system seems to interact with CSF AD biomarkers, such as beta-amyloid and tau proteins. Beta-amyloid accumulation is the main hallmark of AD pathology, while tau proteins mark brain neuronal injury due to AD pathology. Investigations so far suggest that orexinergic signaling overexpression alters the sleep-wake cycle and secondarily induces beta-amyloid accumulation and tau-mediated neurodegeneration. Therefore, considering that orexinergic system dysregulation impairs sleep-wake rhythms and may influence AD pathology, it is hypothesized that orexin receptor antagonists are likely potential preventive/therapeutic options in AD patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1007/7854_2016_50
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Liguori, C. (2016). Orexin and Alzheimer’s Disease. <em>Current topics in behavioral neurosciences</em>. https://doi.org/10.1007/7854_2016_50
Vancouver
Liguori C. Orexin and Alzheimer’s Disease. Current topics in behavioral neurosciences. 2016. doi:10.1007/7854_2016_50.
BibTeX
@article{claudio2016Orexin,
title = {Orexin and Alzheimer’s Disease},
author = {Claudio Liguori},
journal = {Current topics in behavioral neurosciences},
year = {2016},
doi = {10.1007/7854_2016_50},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Alcohol and Alcoholism 2016
Citation only
Alcohol and Alzheimer's Disease—Does Alcohol Dependence Contribute to Beta-Amyloid Deposition, Neuroinflammation and Neurodegeneration in Alzheimer's Disease?
Biochimica et Biophysica Acta (BBA) - Biomembranes 2018
Open access · OA
Impact of membrane curvature on amyloid aggregation
Current Opinion in Psychiatry 2012
Citation only
Sirtuins in cognitive ageing and Alzheimer's disease
Frontiers in aging neuroscience 2026
Open access · OA
Sleep-neuroinflammation interactions in Alzheimer's disease: a systematic review of biomarker pathways.
Journal of Alzheimer s Disease 2025
Open access · CC-BY
Comparative analysis of brain-derived tau oligomer interactomes in Alzheimer's disease, non-demented with Alzheimer's neuropathology, and primary age-related tauopathy: Implications for neurodegeneration and cognitive resilience
NeuroImage 2026
Citation only